Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations

Medical Physics

Volumn 37, Issue 7, 2010, Pages 3809-3816

  Jones, Bernard L ^a   Krishnan, Sunil ^b   Cho, Sang Hyun ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

gold nanoparticles; microscopic dose enhancement; Monte Carlo methods; radiation therapy

Indexed keywords

DEPOSITION; ELECTRON ENERGY LEVELS; ELECTRONS; ELEMENTARY PARTICLE SOURCES; FIBER OPTIC SENSORS; GOLD NANOPARTICLES; IMAGE ENHANCEMENT; METAL NANOPARTICLES; MONTE CARLO METHODS; PHOTONS; RADIATION DAMAGE; RADIOTHERAPY; SCANNING ELECTRON MICROSCOPY; SECONDARY EMISSION; TUMORS;

DOSE ENHANCEMENT FACTORS; DOSE ENHANCEMENTS; GOLD NANOPARTICLES (GNPS); LOW ENERGY PHOTON SOURCE; MONTE CARLO CALCULATION; ORDERS OF MAGNITUDE; PHOTON INTERACTIONS; SECONDARY ELECTRONS;

GOLD METALLOGRAPHY;

GOLD; METAL NANOPARTICLE; WATER;

CHEMISTRY; ELECTRON; MONTE CARLO METHOD; NEOPLASMS; PHOTON; RADIATION DOSE; THERAPEUTIC USE;

ELECTRONS; GOLD; METAL NANOPARTICLES; MONTE CARLO METHOD; NEOPLASMS; PHOTONS; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; WATER;

EID: 77954735630     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3455703     Document Type: Article

References (40)

1. H. F. Dvorak, J. A. Nagy, J. T. Dvorak, and A. M. Dvorak, " Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.," Am. J. Pathol. 0002-9440 133, 95-109 (1988).
2. H. Maeda, J. Fang, T. Inutsuka, and Y. Kitamoto, " Vascular permeability enhancement in solid tumor: Various factors, mechanisms involved and its implications.," Int. Immunopharmacol. 3 (3), 319-328 (2003). 10.1016/S1567-5769(02)00271-0 1567-5769 (Pubitemid 36293960)
3. I. H. El-Sayed, X. Huang, and M. A. El-Sayed, " Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: Applications in oral cancer.," Nano Lett. 1530-6984 5 (5), 829-834 (2005). 10.1021/nl050074e (Pubitemid 40749040)
4. J. A. Copland, M. Eghterdari, V. L. Popov, N. Kotov, N. Mamedova, M. Motamedi, and A. A. Oraevsky, " Bioconjugated gold nanoparticles as a molecular based contrast agent: Implications for imaging of deep tumors using optoacoustic tomography.," Mol. Imaging Biol. 1536-1632 6 (5), 341-349 (2004). 10.1016/j.mibio.2004.06.002 (Pubitemid 39243067)
5. P. Mukherjee, R. Bhattacharya, N. Bone, Y. K. Lee, C. R. Patra, S. Wang, L. Lu, C. Secreto, P. C. Banerjee, M. J. Yaszemski, N. E. Kay, and D. Mukhopadhyay, " Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): Enhancing apoptosis.," J. Nanobiotechnology 5 (4), 4-13 (2007). 1477-3155 10.1186/1477-3155-5-4 (Pubitemid 46851043)
6. J. Li, T. Rajh, C. Pelizzari, S. Chmura, A. Chaudhary, C. Wietholt, P. Redmond, and B. Aydogan, " Deoxyglucose labeled gold nanoparticles as x-ray computed tomography contrast agents for cancer imaging.," Med. Phys. 0094-2405 36 (6), 2775 (2009). 10.1118/1.3182529
7. R. S. Mello, H. Callison, J. Winter, A. R. Kagan, and A. Norman, " Radiation dose enhancement in tumors with iodine.," Med. Phys. 0094-2405 10, 75-78 (1983). 10.1118/1.595378 (Pubitemid 13164049)
8. P. Dawson, M. Penhaligon, E. Smith, and J. Saunders, " Iodinated contrast agents as radiosensitizers.," Br. J. Radiol. 0007-1285 60, 201-203 (1987). 10.1259/0007-1285-60-710-201
9. K. S. Iwamoto, S. T. Cochran, J. Winter, E. Holburt, R. T. Higashida, and A. Norman, " Radiation dose enhancement therapy with iodine in rabbit VX-2 brain tumors.," Radiother. Oncol. 0167-8140 8, 161-170 (1987). 10.1016/S0167-8140(87)80170-6
10. J. H. Rose, A. Norman, and M. Ingram, " First experience with radiation therapy of small brain tumors delivered by a computerized tomography scanner.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 30, 24-25 (1994).
11. A. V. Mesa, A. Norman, T. D. Solberg, J. J. DeMarco, and J. B. Smathers, " Dose distribution using kilovoltage x-ray and dose enhancement from iodine contrast agents.," Phys. Med. Biol. 0031-9155 44, 1955-1968 (1999). 10.1088/0031-9155/44/8/308 (Pubitemid 29387604)
12. J. L. Robar, S. A. Riccio, and M. A. Martin, " Tumor dose enhancement using modified megavoltage photon beams and contrast media.," Phys. Med. Biol. 0031-9155 47, 2433-2449 (2002). 10.1088/0031-9155/47/14/305 (Pubitemid 34823321)
13. F. Verhaegen, B. Reniers, F. Deblois, S. Devic, J. Seuntjens, and D. Hristov, " Dosimetric and microdosimetric study of contrast-enhanced radiotherapy with kilovolt x-rays.," Phys. Med. Biol. 0031-9155 50, 3555-3569 (2005). 10.1088/0031-9155/50/15/005 (Pubitemid 41019096)
14. J. L. Robar, " Generation and modeling of megavoltage photon beams for contrast-enhanced radiation therapy.," Phys. Med. Biol. 0031-9155 51, 5487-5504 (2006). 10.1088/0031-9155/51/21/007 (Pubitemid 44773327)
15. J. F. Hainfeld, D. N. Slatkin, and H. M. Smilowitz, " The use of gold nanoparticles to enhance radiotherapy in mice.," Phys. Med. Biol. 0031-9155 49, N309-N315 (2004). 10.1088/0031-9155/49/18/N03 (Pubitemid 39302700)
16. S. H. Cho, " Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: A preliminary Monte Carlo study.," Phys. Med. Biol. 0031-9155 50 (15), N163-N173 (2005). 10.1088/0031-9155/50/15/N01 (Pubitemid 41019088)
17. J. C. Roeske, L. Nunez, M. Hoggarth, E. Labay, and R. R. Weichselbaum, " Characterization of the theoretical radiation dose enhancement from nanoparticles.," Technol. Cancer Res. Treat. 1533-0346 6, 395-402 (2007).
18. S. H. Cho, B. L. Jones, and S. Krishnan, " Dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low energy gamma-/x-ray sources.," Phys. Med. Biol. 0031-9155 54 (16), 4889-4905 (2009). 10.1088/0031-9155/54/16/004
19. D. C. Medich, M. A. Tries, and J. J. Munro, " Monte Carlo characterization of an ytterbium-169 high dose rate brachytherapy source with analysis of statistical uncertainty.," Med. Phys. 0094-2405 33 (1), 163-172 (2006). 10.1118/1.2147767 (Pubitemid 43121046)
20. I. Kawrakow and D. W. O. Rogers, " The EGSnrc code system.," National Research Council Report No. PIRS-701, 2003.
21. C. C. Ling, E. D. Yorke, I. J. Spiro, D. Kubiatowicz, and D. Bennett, " Physical dosimetry of I 125 seeds of a new design for intersititial implant.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 9, 1747-1752 (1983).
22. Z. Chen and R. Nath, " Dose rate constant and energy spectrum of interstitial brachytherapy sources.," Med. Phys. 0094-2405 28 (1), 86-96 (2001). 10.1118/1.1333748 (Pubitemid 32105396)
23. S. H. Cho, O. N. Vassiliev, S. Lee, H. H. Liu, G. S. Ibbott, and R. Mohan, " Reference photon dosimetry data and reference phase space data for the 6 MV photon beam from Varian Clinac 2100 series linear accelerators.," Med. Phys. 0094-2405 32 (1), 137-148 (2005). 10.1118/1.1829172 (Pubitemid 40165525)
24. M. J. Birch and R. W. Blowes, " A contact x-ray therapy unit for intracavitary irradiation.," Phys. Med. Biol. 0031-9155 35, 275-280 (1990). 10.1088/0031-9155/35/2/008
25. G. Gutman, E. Sozontov, E. Strumban, F. F. Yin, S. W. Lee, and J. H. Kim, " A novel needle-based miniature x-ray generating system.," Phys. Med. Biol. 0031-9155 49, 4677-4688 (2004). 10.1088/0031-9155/49/20/001 (Pubitemid 39433498)
26. M. J. Rivard, S. D. Davis, L. A. DeWerd, T. W. Rusch, and S. Axelrod, " Calculated and measured brachytherapy dosimetry parameters in water for the Xoft Axxent x-ray source: An electronic brachytherapy source.," Med. Phys. 0094-2405 33, 4020-4032 (2006). 10.1118/1.2357021 (Pubitemid 44673094)
27. R. Birch, M. Marshall, and G. M. Ardran, Catalogue of Spectral Data for Diagnostic X-Rays, Scientific Report 30 (Hospital Physicists Association, London, UK, 1979).
28. B. L. Jones, " Monte Carlo calculations of microscopic dose enhancement for gold nanoparticle-aided radiation therapy.," MS thesis, Georgia Institute of Technology, 2009.
29. V. A. Semenenko, J. E. Turner, and T. B. Borak, " NOREC, a Monte Carlo code for simulating electron tracks in liquid water.," Radiat. Environ. Biophys. 0301-634X 42 (3), 213-217 (2003). 10.1007/s00411-003-0201-z (Pubitemid 37518065)
30. S. H. Cho, O. N. Vassiliev, and J. L. Horton, " Comparison between an event-by-event Monte Carlo code, NOREC, and ETRAN for electron scaled point kernels between 20 keV and 1 MeV.," Radiat. Environ. Biophys. 0301-634X 46, 77-83 (2007). 10.1007/s00411-006-0086-8 (Pubitemid 46354804)
31. C. Bousis, D. Emfietzoglou, P. Hadjidoukas, and H. Nikjoo, " A Monte Carlo study of absorbed dose distribution in both the vapor and liquid phases of water by intermediate energy electrons based on different condensed-history transport schemes.," Phys. Med. Biol. 0031-9155 53, 3739-3761 (2008). 10.1088/0031-9155/53/14/003 (Pubitemid 352020264)
32. P. Diagaradjane, A. Shetty, J. Wang, J. Schwartz, A. M. Elliot, S. Shentu, H. C. Park, A. Deorukhkar, R. J. Stafford, S. H. Cho, J. W. Tunnell, J. D. Hazle, and S. Krishnan, " Modulation of in vivo tumor radiation response via gold nanoparticle mediated vascular-focused hyperthermia: Characterizing an integrated antihypoxic and localized vascular disrupting targeting strategy.," Nano Lett. 1530-6984 8 (5), 1492-1500 (2008). 10.1021/nl080496z
33. D. F. Regulla, L. B. Hieber, and M. Seidenbusch, " Physical and biological interface dose effects in tissue due to x-ray-induced release of secondary radiation from metallic gold surfaces.," Radiat. Res. 0033-7587 150, 92-100 (1998). 10.2307/3579649 (Pubitemid 28285629)
34. H. S. Choi, W. Liu, P. Misra, E. Tanaka, J. P. Zimmer, B. Itty Ipe, M. G. Bawendi, and J. V. Fangioni, " Renal clearance of quantum dots.," Nat. Biotechnol. 1087-0156 25, 1165-1170 (2007). 10.1038/nbt1340 (Pubitemid 47538116)
35. J. A. Champion and S. Mitragotri, " Shape induced inhibition of phagocytosis of polymer particles.," Pharm. Res. 0724-8741 26, 244-249 (2009). 10.1007/s11095-008-9626-z
36. Y. Akiyama, T. Mori, Y. Katayama, and T. J. Niidome, " The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice.," J. Controlled Release 139, 81-84 (2009). 10.1016/j.jconrel.2009.06.006
37. H. S. Choi, B. I. Ipe, P. Misra, J. H. Lee, M. G. Bawendi, and J. V. Frangioni, " Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots.," Nano Lett. 1530-6984 9, 2354-2359 (2009). 10.1021/nl900872r
38. F. M. Veronese, " Peptide and protein PEGylation: A review of problems and solutions.," Biomaterials 0142-9612 22, 405-417 (2001). 10.1016/S0142-9612(00)00193-9 (Pubitemid 32007845)
39. P. Diagaradjane, J. M. Orenstein-Cardona, N. E. Colón-Casasnovas, A. Deorukjkar, S. Shentu, N. Kuno, D. L. Schwartz, J. G. Gelovani, and S. Krishnan, " Imaging epidermal growth factor receptor expression in vivo: Pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe.," Clin. Cancer Res. 1078-0432 14, 731-741 (2008). 10.1158/1078-0432.CCR-07-1958 (Pubitemid 351231154)
40. J. E. Riviere, " Pharmacokinetics of nanomaterials: An overview of carbon nanotubes, fullerenes and quantum dots.," Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 1, 26-34 (2009). 10.1002/wnan.24